Jessica M. Ruck MD PhD , Shi Nan Feng BSPH , Mary G. Bowring MPH , Alice L. Zhou MS , Jinny S. Ha MD MHS , Antonio Polanco MD , Christian A. Merlo MD MPH , Errol L. Bush MD
{"title":"Lung Transplant Outcomes by Surgeon Practice and Volume","authors":"Jessica M. Ruck MD PhD , Shi Nan Feng BSPH , Mary G. Bowring MPH , Alice L. Zhou MS , Jinny S. Ha MD MHS , Antonio Polanco MD , Christian A. Merlo MD MPH , Errol L. Bush MD","doi":"10.1016/j.jhlto.2025.100237","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Lung transplants (LT) are performed by surgeons whose practice may include only lung transplants (LT) or lung and heart transplants (L&HT). We examined whether LT outcomes differed by surgeon practice and volume.</div></div><div><h3>Methods</h3><div>We identified all LT in adult U.S. recipients 05/2007-06/2022 using OPTN. We classified surgeons by practice (LT vs. L&HT) and transplant volume (2-20, 21-40, 41-60, or >60) and compared post-transplant morbidity and mortality using multivariable regression adjusted for donor, recipient, and transplant characteristics.</div></div><div><h3>Results</h3><div>Of 635 surgeons, 331 (51.1%) were LT and 304 (47.9%) were L&HT surgeons. They performed 30,223 transplants, including 9,807 (32.5%) by LT and 20,416 (67.5%) by L&HT surgeons. Recipients of transplants by L&HT vs. LT surgeons were less likely to receive post-transplant ECMO (7.9% vs. 8.5%; aOR 0.86, 0.76-0.97, p=0.02) but had similar odds of prolonged ventilation (31.3% vs. 31.5%; aOR 1.01, 95% CI 0.94-1.08, p=0.87), reintubation (18.6% vs. 18.3%; aOR 1.04, 0.98-1.11, p=0.20), airway dehiscence (1.5% vs. 1.6%; aOR 1.01., 0.82-1.23, p=0.94), and 1-year rejection (24.1% vs. 23.0%; aOR 1.04, 0.98-1.12, p=0.20), and they had 4% higher risk of 10-year mortality (70.0% vs. 67.6%; aHR 1.04, 95% CI 1.00-1.08, p=0.046). Additionally, performing >60 lung transplants over the study period was associated with 7% lower 5-year mortality compared to performing only 2-20 transplants (aHR 0.93, 95% CI 0.88-0.98, p=0.004).</div></div><div><h3>Conclusions</h3><div>Surgeons’ practice patterns and lung transplant volume were significantly associated with post-transplant mortality, indicating the importance of experience in achieving optimal outcomes for a technically difficult procedure such as a lung transplant.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"8 ","pages":"Article 100237"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHLT Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950133425000321","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Lung transplants (LT) are performed by surgeons whose practice may include only lung transplants (LT) or lung and heart transplants (L&HT). We examined whether LT outcomes differed by surgeon practice and volume.
Methods
We identified all LT in adult U.S. recipients 05/2007-06/2022 using OPTN. We classified surgeons by practice (LT vs. L&HT) and transplant volume (2-20, 21-40, 41-60, or >60) and compared post-transplant morbidity and mortality using multivariable regression adjusted for donor, recipient, and transplant characteristics.
Results
Of 635 surgeons, 331 (51.1%) were LT and 304 (47.9%) were L&HT surgeons. They performed 30,223 transplants, including 9,807 (32.5%) by LT and 20,416 (67.5%) by L&HT surgeons. Recipients of transplants by L&HT vs. LT surgeons were less likely to receive post-transplant ECMO (7.9% vs. 8.5%; aOR 0.86, 0.76-0.97, p=0.02) but had similar odds of prolonged ventilation (31.3% vs. 31.5%; aOR 1.01, 95% CI 0.94-1.08, p=0.87), reintubation (18.6% vs. 18.3%; aOR 1.04, 0.98-1.11, p=0.20), airway dehiscence (1.5% vs. 1.6%; aOR 1.01., 0.82-1.23, p=0.94), and 1-year rejection (24.1% vs. 23.0%; aOR 1.04, 0.98-1.12, p=0.20), and they had 4% higher risk of 10-year mortality (70.0% vs. 67.6%; aHR 1.04, 95% CI 1.00-1.08, p=0.046). Additionally, performing >60 lung transplants over the study period was associated with 7% lower 5-year mortality compared to performing only 2-20 transplants (aHR 0.93, 95% CI 0.88-0.98, p=0.004).
Conclusions
Surgeons’ practice patterns and lung transplant volume were significantly associated with post-transplant mortality, indicating the importance of experience in achieving optimal outcomes for a technically difficult procedure such as a lung transplant.
目的肺移植(LT)是由只进行肺移植(LT)或肺心脏移植(LT)的外科医生进行的。我们检查了肝移植的结果是否因外科医生的实践和容积而不同。方法:我们于2007年5月至2022年6月使用OPTN对美国所有成年LT接受者进行鉴定。我们根据手术实践(LT vs. L&;HT)和移植量(2- 20,21 - 40,41 -60,或>;60)对外科医生进行分类,并使用调整供体、受体和移植特征的多变量回归比较移植后发病率和死亡率。结果635例外科医生中,肝移植331例(51.1%),肝移植304例(47.9%)。他们进行了30223例移植手术,其中9807例(32.5%)采用肝移植,20416例(67.5%)采用肝移植。L&;HT与LT手术的移植受者接受移植后ECMO的可能性较低(7.9% vs 8.5%;aOR 0.86, 0.76-0.97, p=0.02),但延长通气的几率相似(31.3% vs. 31.5%;aOR 1.01, 95% CI 0.94-1.08, p=0.87),再插管(18.6% vs. 18.3%;aOR 1.04, 0.98-1.11, p=0.20),气道破裂(1.5% vs. 1.6%;优势比1.01。, 0.82-1.23, p=0.94), 1年排斥反应(24.1% vs. 23.0%;aOR 1.04, 0.98-1.12, p=0.20), 10年死亡率高4% (70.0% vs 67.6%;aHR 1.04, 95% CI 1.00-1.08, p=0.046)。此外,与仅进行2-20例肺移植相比,在研究期间进行60例肺移植的5年死亡率降低7% (aHR 0.93, 95% CI 0.88-0.98, p=0.004)。结论:外科医生的实践模式和肺移植量与移植后死亡率显著相关,表明经验对于实现肺移植等技术难度较大的手术的最佳结果非常重要。